ResearcherTokyo Medical UniversityNo recent work listed
Makoto Sunamura
Matched on OpenAlex author ID A5040794653. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 40
2011: 1 paper · 2012: 1 paper · 2013: 3 papers · 2014: none · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper
Papers 10
- Overexpression of hydroxyproline via EGLN/HIF1A is associated with distant metastasis in pancreatic cancer. First author PMID 32905516↗
- Elevated Polyamines in Saliva of Pancreatic Cancer. Last author DOI 10.3390/cancers10020043↗
- NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers. Co-author DOI 10.1016/j.bbrc.2017.01.055↗
- Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. Last author DOI 10.3390/ijms18040767↗
- Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. Co-author DOI 10.1111/cas.12621↗
- S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells. Co-author DOI 10.1007/s10585-012-9532-y↗
- Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2013.10.010↗
- The expression of S100A4 in human pancreatic cancer is associated with invasion. Co-author DOI 10.1097/mpa.0b013e31828804e7↗
- S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. Co-author DOI 10.1016/j.bbrc.2012.10.048↗
- Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with methyl-CpG targeted transcriptional activ… Co-author DOI 10.1016/j.bbrc.2011.06.121↗
Closest collaborators
The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shigeyuki Kawachi · 3 shared papers, 2017–2020 · strength 0.21
- Paper Overexpression of hydroxyproline via EGLN/HIF1A is associated with distant metastasis in pancreatic cancer. PMID 32905516↗
- Paper Elevated Polyamines in Saliva of Pancreatic Cancer. DOI 10.3390/cancers10020043↗
- Paper Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. DOI 10.3390/ijms18040767↗
- Akira Horii · 5 shared papers, 2011–2017 · strength 0.18
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with m… DOI 10.1016/j.bbrc.2011.06.121↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Shinichi Fukushige · 4 shared papers, 2011–2017 · strength 0.15
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with m… DOI 10.1016/j.bbrc.2011.06.121↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Michiaki Unno · 4 shared papers, 2011–2017 · strength 0.15
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with m… DOI 10.1016/j.bbrc.2011.06.121↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Fuyuhiko Motoi · 4 shared papers, 2011–2017 · strength 0.15
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with m… DOI 10.1016/j.bbrc.2011.06.121↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Yuriko Saiki · 4 shared papers, 2012–2017 · strength 0.15
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Paper S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. DOI 10.1016/j.bbrc.2012.10.048↗
- Akihiro Yamamura · 3 shared papers, 2013–2017 · strength 0.12
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Paper The expression of S100A4 in human pancreatic cancer is associated with invasion. DOI 10.1097/mpa.0b013e31828804e7↗
- Reina Tanaka · 2 shared papers, 2017–2018 · strength 0.11
- Atsushi Sofuni · 2 shared papers, 2017–2018 · strength 0.11
- Yuichi Nagakawa · 2 shared papers, 2017–2018 · strength 0.11
- Ryosuke Tonozuka · 2 shared papers, 2017–2018 · strength 0.11
- Takao Itoi · 2 shared papers, 2017–2018 · strength 0.11
- Toru Sano · 1 shared paper, 2020 · strength 0.10
- Naokazu Chiba · 1 shared paper, 2020 · strength 0.10
- Koichi Tomita · 1 shared paper, 2020 · strength 0.10
- Shinichi Egawa · 3 shared papers, 2011–2013 · strength 0.08
- Paper Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with m… DOI 10.1016/j.bbrc.2011.06.121↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Paper The expression of S100A4 in human pancreatic cancer is associated with invasion. DOI 10.1097/mpa.0b013e31828804e7↗
- Shuntaro Mukai · 1 shared paper, 2018 · strength 0.06
- Yasutsugu Asai · 1 shared paper, 2018 · strength 0.06
- Kenjiro Yamamoto · 1 shared paper, 2018 · strength 0.06
- Yukitoshi Matsunami · 1 shared paper, 2018 · strength 0.06
- Hiroki Nagase · 2 shared papers, 2012–2013 · strength 0.06
- Yuta Abe · 1 shared paper, 2017 · strength 0.05
- Kazuhiko Kasuya · 1 shared paper, 2017 · strength 0.05
- Fuminori Moriyasu · 1 shared paper, 2017 · strength 0.05
- Koichi Aiura · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.